Mississippi Administrative Code › Title 15 - Mississippi Department of Health › Part 22 - Medical Cannabis Program › Subpart 1 - Cannabis Testing Facilities › Chapter 1 - REGULATIONS FOR CANNABIS TESTING FACILITY › Subchapter 1 - General Provisions › Rule 15-22-1-1.1.2 - Definitions

Current through June 25, 2024
1.
"Accreditation"
means being currently deemed as technically
					 competent under ISO/IEC 17025:2017 by an international mutual recognition
					 arrangement signatory that has been found to meet ISO/IEC 17011, Conformity
					 Assessment-Requirements for accreditation bodies accrediting conformity
					 assessment bodies.
2.
"Accreditation Body"
means an impartial non-profit organization
					 that operates in conformance with the International Organization for
					 Standardization (ISO) / International Electrotechnical Commission (IEC)
					 standard 17011 and is a signatory to the International Laboratory Accreditation
					 Cooperation (ILAC) Mutual Recognition Arrangement (MRA) for Testing.
3.
"Analytical Batch"
means a
					 set of no more than twenty samples that are prepared together for the same type
					 of analysis, are sequentially analyzed using the same instrument calibration
					 curve, and have common analytical quality control requirements. The batch shall
					 include testing samples as well as all applicable quality control samples, to
					 include one method blank, duplicate laboratory fortified blanks, and duplicate
					 matrix spikes, as required by the analytical method.
4.
"Batch"
means, with regard to
					 usable medical cannabis, a homogenous, identified quantity of usable medical
					 cannabis, no greater than twenty-five (25) pounds, that is harvested during a
					 specified time period from a specified cultivation area, and with regard to
					 oils vapors and waxes derived from usable medical cannabis, means an identified
					 quantity that is uniform, that is intended to meet specifications for identity,
					 strength, and composition, and that is manufactured, packaged and labeled
					 during a specified time period according to a single manufacturing, packaging
					 and labeling protocol.
5.
"Cannabis"
means all parts of the plant of the genus cannabis, the
					 flower, the seeds thereof, the resin extracted from any part of the plant and
					 every compound, manufacture, salt, derivative, mixture or preparation of the
					 plant, its seeds or its resin, including whole plant extracts. Such term shall
					 not mean cannabis-derived drug products approved by the federal Food and Drug
					 Administration under Section 505 of the Federal Food, Drug, and Cosmetic
					 Act.
6.
"Cannabis
					 Products"
means cannabis flower, concentrated cannabis, cannabis
					 extracts and products that are infused with cannabis or an extract thereof and
					 are intended for use or consumption by humans. The term includes, without
					 limitation, edible cannabis products, beverages, topical products, ointments,
					 oils, tinctures and suppositories that contain tetrahydrocannabinol (THC)
					 and/or cannabidiol (CBD) except those products excluded from control under
					 Sections 41-29-113 and
					 41-29-136, Mississippi Code of
					 1972, as amended.
7.
"Cannabinoid Extract"
means a substance obtained by separating
					 cannabinoids from cannabis by any of the following methods:
A. A chemical extraction process using a
					 hydrocarbon-based solvent; or
B. A
					 chemical extraction process using the hydrocarbon-based solvent carbon dioxide,
					 if the process uses high heat or pressure.